Healthy Volunteers



Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer


Condition:   Healthy Volunteers
Intervention:   Drug: Prasaprohyai
Sponsors:   Thammasat University;   Thai Traditional Medical Knowledge Fund
Not yet recruiting - verified March 2017


A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers


Condition:   Healthy Volunteers
Interventions:   Drug: PR1;   Other: PL1
Sponsor:   UCB Biopharma S.P.R.L.
Completed - verified February 2017


Prolonged Hypoxic Breathing in Healthy Volunteers: a Safety Study


Condition:   Healthy Volunteers
Intervention:   Drug: Inhaled Nitrogen
Sponsors:   Massachusetts General Hospital;   Rezoagli, Emanuele, M.D., Massachusetts General Hospital, Harvard Medical School;   Ferrari, Michele, M.D., Massachusetts General Hospital, Harvard Medical School;   Patel, Sarvagna, B.A., Massachusetts General Hospital, Harvard Medical School;   Zapol, Warren M., M.D., Massachusetts General Hospital, Harvard Medical School;   Fisher, Daniel, R.R.T., Massachusetts General Hospital, Harvard Medical School;   Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School;   Mootha, Vamsi, M.D., Massachusetts General Hospital, Harvard Medical School;   Harris, Stuart N., M.D., Massachusetts General Hospital, Harvard Medical School;   Karaa, Amel, M.D., Massachusetts General Hospital, Harvard Medical School
Recruiting - verified March 2017


A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants


Condition:   Healthy Volunteer
Interventions:   Drug: GDC-0276 capsule;   Drug: GDC-0276 tablets
Sponsor:   Genentech, Inc.
Withdrawn - verified March 2017


Whole Blood Specimen Collection From Healthy Subjects


Condition:   Healthy Volunteers
Intervention:   Other: Whole blood
Sponsor:   Progenity, Inc.
Recruiting - verified June 2016


The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: Placebo;   Drug: RO6889450
Sponsor:   Hoffmann-La Roche
Recruiting - verified November 2016


A Study of HMPL-689 in Healthy Volunteers


Condition:   Healthy Volunteers
Interventions:   Drug: HMPL-689;   Drug: HMPL-689 placebo
Sponsor:   Hutchison Medipharma Limited
Completed - verified March 2017


A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: DSTA4637S;   Drug: Placebo
Sponsor:   Genentech, Inc.
Completed - verified March 2017


Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers


Condition:   Healthy Volunteers
Intervention:   Drug: Lenvatinib
Sponsor:   Eisai Inc.
Completed - verified June 2016


A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study


Condition:   Healthy Volunteer
Intervention:  
Sponsors:   Duke University;   Zenalux Biomedical, Inc.
Completed - verified October 2016


First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers


Condition:   Healthy Volunteers
Interventions:   Drug: LML134;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified October 2016


A Study of High Dose MHAA4549A in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: MHAA4549A;   Drug: MHAA4549A;   Drug: Placebo
Sponsor:   Genentech, Inc.
Completed - verified March 2017


AZD8108 SAD/MAD in Healthy Volunteers


Condition:   Healthy Volunteers
Interventions:   Drug: AZD8108;   Drug: Placebo
Sponsor:   AstraZeneca
Completed - verified March 2017


A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model


Condition:   Healthy Volunteer
Interventions:   Drug: MHAA549A;   Drug: Placebo;   Drug: oseltamivir [Tamiflu]
Sponsor:   Genentech, Inc.
Completed - verified March 2017


Functional Brain Imaging in Healthy Volunteers to Study Cognitive Functions


Condition:   Healthy Volunteers
Intervention:  
Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 11, 2016


A Study of RO6870868 in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: RO6870868;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified November 2016


A Study of RO6799477 in Healthy Volunteers


Condition:   Healthy Volunteer
Intervention:   Drug: RO6799477
Sponsor:   Hoffmann-La Roche
Completed - verified November 2016


Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers


Condition:   Adult Healthy Volunteers
Intervention:   Biological: TAB08
Sponsor:   Theramab LLC
Completed - verified February 2017


ANX-042 Healthy Volunteer Dose Escalation Study


Condition:   Healthy Volunteers
Interventions:   Drug: ANX-042;   Drug: Placebo
Sponsor:   Anexon, Incorporated
Completed - verified March 2017


A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: ribavirin [Copegus];   Drug: ribavirin [Vilona]
Sponsor:   Hoffmann-La Roche
Completed - verified October 2016


A Study of MCAF5352A in Healthy Volunteers


Condition:   Healthy Volunteer
Interventions:   Drug: MCAF5352A;   Drug: Placebo
Sponsor:   Genentech, Inc.
Completed - verified November 2016


Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol


Condition:   Healthy Volunteers
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified December 28, 2016


A Study of RO4917838 With Rosuvastatin in Healthy Volunteers


Condition:   Healthy Volunteer
Intervention:   Drug: RO4917838 and Rosuvastatin
Sponsor:   Hoffmann-La Roche
Completed - verified November 2016


Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies


Condition:   Healthy Volunteers
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Suspended - verified March 30, 2017


Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects


Condition:   Healthy Volunteers
Interventions:   Drug: PT001;   Drug: PT005;   Drug: PT003;   Drug: PT001 + PT005
Sponsor:   Pearl Therapeutics, Inc.
Completed - verified March 2017

Refine Your Search Advanced Search